ArticleTheScientificWorldJournal2014

Neoadjuvant chemotherapy with FOLFOX4 regimen to treat advanced gastric cancer improves survival without increasing adverse events: a retrospective cohort study from a Chinese center.

Zhen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.